No abstract available.
Psoriasis*

No abstract available.
Psoriasis*

No abstract available.
Psoriasis

No abstract available.
Psoriasis*

No abstract available.
Psoriasis*

No abstract available.
Psoriasis*

No abstract available.
Psoriasis*

While evaluating historical aspects of medicine, Greco-Arabic period stands ahead in medical field, before the skills of the 20th century. Their great contributions to medicine by their efforts drew remedies from all across the world. Psoriasis, a skin disorder, most likely as old as mankind is mentioned in the vast classical literature. This review paper mainly highlights the contribution of physicians of Greco-Arab related with psoriasis. Their scientific observation about the disease, gave a brief description about etiopathogenesis, clinical presentation and management of the diseases. Present physicians may not be well aware of the richness of the medical literature about psoriasis. This review gathered a rich source of medical information about the history of psoriasis from the wealth of ancient literature
Psoriasis

No abstract available.
Psoriasis

SUMMARY Introduction: Psoriasis is a common, chronic, relapsing, immune-mediated inflammatory disease. Our objective is to review the clinical profile, co-morbidities, and outcome of patients with psoriasis. Methods: This is a cross-sectional study of outpatient psoriasis patients attending the dermatology clinic, Hospital Sultan Abdul Halim (HSAH) between January 2012 and June 2014. Data collection was based on Malaysian Psoriasis Registry. Results: Among 296 patients with psoriasis, Malays were the most common 175 (59.1%), followed by Indians 82 (27.7%), Chinese 37 (12.5%) and others 2 (0.6%). Male to female ratio was 1.2:1. More than half (54.7%) of the patients had early onset disease (age 40 or less). Only 26 patients (8.8%) have positive family history. The most common clinical presentation was chronic plaque psoriasis (89.9%), followed by erythrodermic psoriasis (4.7%), guttate psoriasis (3.0%) and pustular psoriasis (1.7%). Twenty eight percent had nail involvement while arthropathy was seen only in 14.7%. Common triggers were sunlight (46.0%), stress (31.1%), trauma (5.4%), food (4.0%), pregnancy (4.0%), and upper respiratory tract infections (2.7%). Co-morbidities observed include ischaemic heart disease (7.1%), hypertension (26.7%), dyslipidemia (17.6%), and diabetes mellitus (22.0%). All patients were on topical medications. About 6.8% of the patients were treated with phototherapy. One third of patients (35.5%) were given systemic therapy. Out of these, 84 patients (80.0%) were on methotrexate while only 16 (15.2%) on acitretin. None was on cyclosporine or biologic. In term of disease severity, 41.7% of patients had BSA >10% and 31.4% patients had DLQI > 10. Conclusion: Our patients show a similar clinical profile and outcome as our Malaysian psoriasis population. However they tend to have a more severe disease. There is a need for a more effective targeted therapy for a better outcome.
Psoriasis